MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, KAPA has $5,744K in assets. $3,675K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
1030.86%
Quick Ratio
1030.86%
Cash Ratio
852.67%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Deferred offering costs
    • Less accumulated amortization
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable and accrued exp...
    • Common stock, par value 0.001, 1...

Balance Sheets
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
3,675 4,491 5,575 3,034
Vendor advances, gross
1,756 3,271 3,271 -
Less accumulated amortization
1,131 2,426 2,214 -
Vendor advances, net
625 845 1,057 1,717
Prepaid expenses and other current assets
143 51 24 88
Total current assets
4,443 5,387 6,656 4,839
Deferred offering costs
1,279 1,091 1,308 1,692
Intangible assets, net
22 62 102 142
Total other assets
1,301 1,153 1,410 1,834
Total assets
5,744 6,540 8,066 6,673
Accounts payable and accrued expenses
431 199 402 676
Total current liabilities
431 199 402 676
Common stock, par value 0.001, 100,000,000 shares authorized 21,411,198 and 20,821,353 shares issued and outstanding, respectively
21 21 21 18
Additional paid-in capital
21,208 20,582 20,540 17,478
Accumulated deficit
-15,916 -14,262 -12,897 -11,499
Total shareholders equity
5,313 6,341 7,664 5,997
Total liabilities and shareholders equity
5,744 6,540 8,066 6,673
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Vendor advances, gross$1,756K Cash and cashequivalents$3,675K Vendor advances, net$625K Prepaid expenses andother current assets$143K Deferred offering costs$1,279K Intangible assets, net$22K Less accumulatedamortization$1,131K Total current assets$4,443K Total other assets$1,301K Total assets$5,744K Total liabilities andshareholders equity$5,744K Total shareholdersequity$5,313K Total currentliabilities$431K Accumulated deficit-$15,916K Additional paid-in capital$21,208K Accounts payable andaccrued expenses$431K Common stock, par value0.001, 100,000,000...$21K

Kairos Pharma, LTD. (KAPA)

Kairos Pharma, LTD. (KAPA)